Goldman Sachs’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
|
|||||
2024
Q2 | $930K | Buy |
|
|||||
2024
Q1 | $358K | Buy |
|
|||||
2023
Q4 | $62.1K | Sell |
|
|||||
2023
Q3 | $67.3K | Sell |
|
|||||
2023
Q2 | $139K | Sell |
|
|||||
2023
Q1 | $524K | Buy |
|
|||||
2022
Q2 | – | Sell |
|
|||||
2022
Q1 | $184K | Sell |
|
|||||
2021
Q4 | $257K | Buy |
|
|||||
2021
Q3 | $170K | Buy |
|
|||||
2021
Q2 | – | Sell |
|
|||||
2021
Q1 | $95K | Buy |
|
|||||
2020
Q4 | $42K | Buy |
|
|||||
2018
Q4 | – | Sell |
|
|||||
2018
Q3 | $88K | Sell |
|
|||||
2018
Q2 | $149K | Buy |
|
|||||
2018
Q1 | $24K | Buy |
|
|||||
2017
Q3 | – | Sell |
|
|||||
2017
Q2 | $374K | Buy |
|
|||||
2017
Q1 | – | Sell |
|
|||||
2016
Q4 | $361K | Buy |
|
|||||
2016
Q3 | – | Sell |
|
|||||
2016
Q2 | $453K | Buy |
|